Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$494K Buy
136,949
+37,641
+38% +$130K ﹤0.01% 2841
2025
Q4
$339K Sell
99,308
-1,224,091
-92% -$5.94M ﹤0.01% 3009
2025
Q3
$8.99M Buy
1,323,399
+157,006
+13% +$1.3M ﹤0.01% 1615
2025
Q2
$15.9M Buy
1,166,393
+882,362
+311% +$8.33M ﹤0.01% 1241
2025
Q1
$1.55M Sell
284,031
-129,470
-31% -$735K ﹤0.01% 2447
2024
Q4
$2.05M Buy
413,501
+129,470
+46% +$679K ﹤0.01% 2378
2024
Q3
$1.49M Hold
284,031
﹤0.01% 2571
2024
Q2
$1.95M Buy
+284,031
New +$2.6M ﹤0.01% 2411

Other funds holding LFMD

Nuveen's LFMD Position: Q1 2026 in Review

Nuveen increased its LifeMD (LFMD) stake by 38% in Q1 2026, buying an estimated $130K and bringing the position to 136,949 shares worth $494K. The position accounts for ﹤0.01% of the portfolio, ranked #2841.

Nuveen first reported a position in LFMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $15.9M in Q2 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • Nuveen held 136,949 shares of LifeMD worth $494K as of Q1 2026.
  • Nuveen bought 37,641 LifeMD shares in Q1 2026, an estimated $130K.
  • LifeMD made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2841 holding.
  • Nuveen first reported a position in LifeMD in Q2 2024 and has held it in 8 quarters since.
  • Nuveen's LifeMD position peaked at $15.9M in Q2 2025.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.